New indications for exenatide therapy of type 2 diabetes mellitus

New indications for exenatide therapy of type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus(DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenatid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2010-09-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus obesity incretin mimetics exenatide byetta
Online Access:	https://www.dia-endojournals.ru/jour/article/view/5496
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01)

Liraglutide for the treatment of obesity
by: Elmien Bronkhorst, et al.
Published: (2016-05-01)

Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
by: Alina Babenko, et al.
Published: (2014-12-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
by: E. V. Pokrovskaya, et al.
Published: (2021-02-01)

Diabetes mellitus type 2 in adults
by: Ivan I. Dedov, et al.
Published: (2020-06-01)

A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide
by: Laura Patton, et al.
Published: (2025-07-01)

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)
by: Ivan I. Dedov, et al.
Published: (2016-05-01)

Features of the functional state of the enteropancreatic hormonal system in pregnant women with gestational diabetes mellitus
by: F. O. Ushanova, et al.
Published: (2023-12-01)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
by: Marina Vladimirovna Shestakova, et al.
Published: (2016-01-01)

Recent advances in the treatment of type 2 diabetes mellitus with obesity
by: S. V. Yargin
Published: (2021-06-01)

Comments to: ?Type 2 diabetes mellitus ? time to change the concept?
by: Oleg Viktorovich Udovichenko
Published: (2014-03-01)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

HbA1c Level in Type 2 Diabetes Mellitus Patients With and Without Obesity in An Indonesian Regional Hospital
by: Fritsal Tinangon, et al.
Published: (2025-06-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Role of adiponektin and leptin in the development of metabolic syndrome and related obesity and type II diabetes mellitus
by: E. A. Shevchenko, et al.
Published: (2022-03-01)

Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
by: Natalya S. Bordan, et al.
Published: (2017-08-01)

Predictive value of obesity-related indices for incident type 2 diabetes mellitus: a longitudinal study of the Fukushima Health Database 2015–2021
by: Enbo Ma, et al.
Published: (2025-06-01)

Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive
by: Marina Vladimirovna Shestakova
Published: (2012-12-01)

Molecular and morphological peculiarities of chronic placental insufficiency formation caused by different types of diabetes mellitus
by: Tatyana G. Tral, et al.
Published: (2020-06-01)

Bone fractures in patients with type 2 diabetes mellitus: prevalence and risk factors
by: Tatiana Olegovna Yalochkina, et al.
Published: (2016-11-01)

A case of severe ketoacidosis as the first clinical manifestation of type 2 diabetes mellitus in a youngster
by: Bruno Bombaci, et al.
Published: (2025-01-01)

Management of hypertension in patients with type 2 diabetes mellitus
by: M.L.I. Mashitisho
Published: (2013-02-01)

Association of polymorphisms of the ADIPOQ, ADIPOR1 and ADIPOR2 genes with type 2 diabetes mellitus
by: Dmitry Sergeevich Khodyrev, et al.
Published: (2015-06-01)

Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report
by: Hidetaka Ichikawa, et al.
Published: (2021-01-01)

Diabetes mellitus as an economic problem in Russian Federation
by: Ivan Ivanovich Dedov, et al.
Published: (2016-01-01)

Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population
by: O. M. Drapkina, et al.
Published: (2018-11-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024-01-01)

Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats
by: Chen Gilor, et al.
Published: (2025-03-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
by: E. V. Eliseeva, et al.
Published: (1970-01-01)

Peptide Co-Agonists for Combined Activation of the APJ and GLP-1 Receptors with Insulinotropic and Satiety Actions Show Potential for Alleviation of Metabolic Dysfunction in Type 2 Diabetes
by: Finbarr O’Harte, et al.
Published: (2023-12-01)

Analysis of the Role of Neurospecific Proteins in the Diagnosis of Cognitive Dysfunction in Patients with Type 1 Diabetes Mellitus
by: Yulia Gennad'evna Samoylova, et al.
Published: (2014-07-01)

The role of the gut microbiota in the development of type 1 diabetes mellitus
by: L. I. Ibragimova, et al.
Published: (2021-02-01)

Adherence to medicamentous therapy of type 2 diabetes mellitus: results of patient questionnaires
by: Elena Viktorovna Surkova, et al.
Published: (2009-03-01)

Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017
by: Ivan I. Dedov, et al.
Published: (2018-08-01)

Combination of osteogenesis imperfecta and type 1 diabetes mellitus
by: D. A. Marmalyuk, et al.
Published: (2022-01-01)

A review of mortality in type 2 diabetes mellitus
by: Nailya Sayfullaevna Asfandiyarova
Published: (2015-12-01)

The nursing care in a child with type 1 diabetes mellitus: a report of an experience
by: Daniele Mary Silva de Brito, et al.
Published: (2006-02-01)

Cognitive impairments in type 1 diabetes mellitus
by: Yu. V. Bykov, et al.
Published: (2023-02-01)